The largest purchase of all time was on 2023-05-15 and amounted to 101740 shares of Y-mAbs Therapeutics, Inc. for $981,404.
The largest sale of all time was on 2021-06-09 and amounted to 116700 shares of Y-mAbs Therapeutics, Inc. for $4.22M.
No biography is available at this moment.
| 2023-12-11 | Y-mAbs Therapeutics, Inc. YMAB | director | 109,318 0.2637% | $7.00 | $765,075 | +98.95% | ||
| 2023-12-08 | Y-mAbs Therapeutics, Inc. YMAB | director | 18,503 0.0418% | $6.99 | $129,379 | +86.74% | ||
| 2023-12-07 | Y-mAbs Therapeutics, Inc. YMAB | director | 6,183 0.0135% | $6.50 | $40,190 | +94.63% | ||
| 2023-11-29 | Y-mAbs Therapeutics, Inc. YMAB | director | 51,837 0.1191% | $5.97 | $309,477 | +121.27% | ||
| 2023-11-28 | Y-mAbs Therapeutics, Inc. YMAB | director | 30,671 0.0702% | $5.81 | $178,275 | +127.76% | ||
| 2023-11-27 | Y-mAbs Therapeutics, Inc. YMAB | director | 62,516 0.1416% | $5.49 | $343,019 | +138.18% | ||
| 2023-05-15 | Y-mAbs Therapeutics, Inc. YMAB | director | 101,740 0.2186% | $9.65 | $981,404 | -31.03% | ||
| 2021-06-10 | Sale | Y-mAbs Therapeutics, Inc. YMAB | director | 11,229 0.0248% | $36.15 | $405,971 | -54.57% | |
| 2021-06-09 | Sale | Y-mAbs Therapeutics, Inc. YMAB | director | 116,700 0.2664% | $36.19 | $4.22M | -53.05% | |
| 2021-06-08 | Sale | Y-mAbs Therapeutics, Inc. YMAB | director | 33,300 0.0756% | $35.28 | $1.17M | -52.03% | |
| 2021-06-07 | Sale | Y-mAbs Therapeutics, Inc. YMAB | 10 percent owner | 72,400 0.1618% | $34.15 | $2.47M | -51.15% | |
| 2021-06-04 | Sale | Y-mAbs Therapeutics, Inc. YMAB | 10 percent owner | 3,841 0.009% | $34.03 | $130,704 | -48.25% | |
| 2021-06-03 | Sale | Y-mAbs Therapeutics, Inc. YMAB | 10 percent owner | 30,666 0.0694% | $33.19 | $1.02M | -48.77% | |
| 2021-06-01 | Sale | Y-mAbs Therapeutics, Inc. YMAB | 10 percent owner | 6,864 0.016% | $35.57 | $244,173 | -50.49% | |
| 2021-05-28 | Sale | Y-mAbs Therapeutics, Inc. YMAB | 10 percent owner | 25,000 0.0582% | $36.34 | $908,475 | -51.42% |